SURG
Surgepays Inc
0.1496$
-0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 33.55 | 0.75 | 0.29 | 0.11 | 0.08 | 142.69 | 4.26 | – | 8.83 | 9.34 | 13.38 | 25.49 | 11.65 | 9.81 | 9.19 | 3.18 | 2.84 | |
| – | 129.89 | 3.55 | 0.55 | 0.06 | 0.06 | 89.52 | 3.51 | – | 5.31 | 5.25 | 11.76 | 24.33 | 10.25 | 8.72 | 6.80 | 3.93 | 3.36 | |
| – | -96.34 | -2.80 | -0.26 | 0.05 | 0.01 | 53.17 | 0.75 | – | 3.52 | 4.09 | 1.62 | 1.16 | 1.41 | 1.09 | 2.39 | -0.75 | -0.53 | |
| – | – | – | – | 0.00 | 0.00 | – | 0.00 | – | 0.00 | – | – | – | – | – | – | – | – | |
| 70.42 | 368.42 | 53.72 | 22.48 | 34.83 | 1.95 | 2.67 | 1.79 | – | 3.10 | 4.60 | 4.45 | 4.41 | 2.45 | 0.94 | 1.04 | 1.37 | 0.99 | |
| 59.53 | 383.02 | 53.76 | 22.57 | 34.83 | 1.96 | 51.50 | 2.74 | – | 3.39 | 5.03 | 5.66 | 5.91 | 2.78 | 1.04 | 1.12 | 1.44 | 1.17 | |
| -71.86 | -383.02 | -56.56 | -22.83 | -34.78 | -1.95 | 1.67 | -1.99 | – | 0.13 | -0.94 | -4.04 | -4.75 | -1.37 | 0.05 | 1.26 | -2.19 | -1.70 | |
| 0.16 | 383.02 | 0.04 | 2.24 | 0.70 | 2.00 | 0.64 | 0.02 | – | 0.02 | 0.09 | 0.12 | 1.85 | 1.72 | 0.16 | 0.04 | 0.03 | 0.10 | |
| -84.18 | -383.02 | -91.36 | -27.90 | -34.97 | -3.32 | 1.78 | -2.01 | – | 1.82 | -0.89 | -4.39 | -5.02 | -3.09 | -0.04 | 1.23 | -2.25 | -1.80 | |
| 0.16 | 383.02 | 34.78 | 5.66 | -1.03 | 1.38 | 1.40 | 0.02 | – | 0.28 | 0.05 | -0.12 | 2.90 | 1.20 | -0.03 | -0.15 | 0.15 | – | |
| -72.02 | -383.02 | -91.36 | -27.90 | -34.97 | -3.32 | 1.78 | -2.01 | – | 1.82 | -0.94 | -4.39 | -5.02 | -3.09 | -0.05 | 1.38 | -2.39 | -1.80 | |
| -47.21 | -383.02 | -56.08 | -25.57 | -34.26 | -1.32 | 2.49 | -1.23 | – | 0.14 | -0.72 | -4.13 | -2.53 | -1.16 | 0.19 | 1.35 | -2.16 | -1.64 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.